Latest News about RHHBY

Recent news which mentions RHHBY

...

7 8 9 10 11 12 13 14 15

...

Why Regeneron Pharmaceuticals Stock Is Crushing It Today

September 08, 2022

No More Free COVID-19 At-Home Tests, Federal Government Says

August 29, 2022

Citi Is Bullish On This Large Pharma Stock On Upcoming Data Readout From Diabetes Candidate

August 25, 2022

China-Based Jemincare Inks Prostate Cancer Drug Pact With Roche's Genentech

August 18, 2022

Roche's Polivy Combo Regime Under FDA Review For Type Of Blood Cancer

August 16, 2022

OTC Markets' Most Active Securities Sees A Shake-up In July

August 16, 2022

FDA Approves Expanded Use Of Roche's Influenza Treatment

August 12, 2022

Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial

August 10, 2022

Amgen's Lumakras/Keytruda/Tecentriq Combo Data Flags Safety Concern

August 08, 2022

These 2 Under-The-Radar Stocks Traded More Than $1B Each Last Month

August 05, 2022

Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial

August 03, 2022

Kiniksa Inks Global License Agreement With Roche For Vixarelimab

August 03, 2022

Poseida Shares Rally As Roche Takes Next Big Step Into Allogeneic CAR-T Field

August 03, 2022

Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study

August 02, 2022

How This Multibillion-Dollar Company Is Shaking Off the Competition

July 30, 2022

Daily Biotech Pulse: Bausch Health To Appeal Xifaxan Patent Decision, Bristol Myers Drug Combo Fails In Kidney Cancer Trial, Sarepta's Duchenne Candidate Update

July 29, 2022

Why Shares of Agenus Inc. Rose 10.1% on Tuesday

July 26, 2022

Regeneron's Price Target Cut On Dim Prospects For Its Flagship Eye Product

July 25, 2022

Daily Biotech Pulse: Liver Disease-Focused Gene Therapy Pact, Assembly Bio Stops HBV Infection Trial, X4 Pharma Looks For Partners

July 21, 2022

Benzinga Before The Bell: Baidu Beats Tesla, Finland Sells $47.5M Bitcoins, Tesla's Bitcoin Sale And Other Top Financial Stories Thursday, July 21

July 21, 2022

Roche's Long-Time CEO Passes Baton, Higher Diagnostics, Medicine Sales Lift 1H Sales & Profit

July 21, 2022

Novartis Posts Mixed Q2 Earnings, Expects Improved Earnings At Sandoz

July 19, 2022

Mortgage Financiers & Crypto Securities Reclaim Their Spots As Most Actively Traded Securities On OTC Markets In June

July 18, 2022

Roche Launches Dual Antigen & Antibody Hepatitis C Diagnostic Test

July 18, 2022

New Data Reinforce Favorable Safety, Efficacy Of Roche's Hemlibra For Hemophilia A

July 11, 2022

The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After

July 11, 2022

10 Most Traded OTC Stocks In June: Where Do Danone, Adidas And Grayscale Bitcoin Trust Rank?

July 06, 2022

Sarepta Reports One Heart Inflammation Case In Duchenne Gene Therapy Trial

July 06, 2022

The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer's Drug Due In January, FDA Reviews Roche's Lymphoma Candidate, Rare Pediatric Tag For Kazia's Pediatric Brain Cancer Candidate

July 06, 2022

The OTC Markets' Most-Active Securities Embrace International Operators As Volatility Envelops Markets In May

June 17, 2022

...

7 8 9 10 11 12 13 14 15

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.